Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections.

Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G.

Clin Microbiol Infect. 2014 May;20(5):O318-24. doi: 10.1111/1469-0691.12407. Epub 2013 Nov 6.

2.

Attributable cost and length of stay for central line-associated bloodstream infections.

Goudie A, Dynan L, Brady PW, Rettiganti M.

Pediatrics. 2014 Jun;133(6):e1525-32. doi: 10.1542/peds.2013-3795. Epub 2014 May 5.

3.

Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.

Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ.

Crit Care Med. 2006 Aug;34(8):2084-9.

PMID:
16763511
4.

The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.

Tedja R, Gordon SM, Fatica C, Fraser TG.

Infect Control Hosp Epidemiol. 2014 Feb;35(2):164-8. doi: 10.1086/674856. Epub 2013 Dec 23.

PMID:
24442079
5.

Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.

Rhee Y, Heung M, Chen B, Chenoweth CE.

Infect Control Hosp Epidemiol. 2015 Apr;36(4):424-30. doi: 10.1017/ice.2014.86.

PMID:
25782897
6.

Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis.

Ziegler MJ, Pellegrini DC, Safdar N.

Infection. 2015 Feb;43(1):29-36. doi: 10.1007/s15010-014-0689-y. Epub 2014 Oct 21. Review.

PMID:
25331552
7.

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ.

Crit Care Med. 2003 May;31(5):1312-7.

PMID:
12771596
8.

Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.

Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK; Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program.

Clin Infect Dis. 2012 Jul;55(2):232-41. doi: 10.1093/cid/cis408. Epub 2012 Apr 20.

9.

The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.

Concannon C, van Wijngaarden E, Stevens V, Dumyati G.

Infect Control Hosp Epidemiol. 2014 Sep;35(9):1140-6. doi: 10.1086/677634. Epub 2014 Jul 28.

PMID:
25111922
10.

Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit.

Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA.

Arch Surg. 2001 Feb;136(2):229-34.

PMID:
11177147
11.

Impact of nosocomial infection on cost of illness and length of stay in intensive care units.

Chen YY, Chou YC, Chou P.

Infect Control Hosp Epidemiol. 2005 Mar;26(3):281-7.

PMID:
15796281
12.

Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.

Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH.

Clin Infect Dis. 2005 Dec 1;41(11):1591-8. Epub 2005 Oct 25.

13.

Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.

Primo MG, Guilarde AO, Martelli CM, Batista LJ, Turchi MD.

Braz J Infect Dis. 2012 Nov-Dec;16(6):503-9. doi: 10.1016/j.bjid.2012.10.001. Epub 2012 Nov 15.

14.

Cost of intensive care unit-acquired bloodstream infections.

Laupland KB, Lee H, Gregson DB, Manns BJ.

J Hosp Infect. 2006 Jun;63(2):124-32. Epub 2006 Apr 18.

PMID:
16621137
15.

Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Mar 4;60(8):243-8.

16.

Risk factors for central line-associated bloodstream infection in pediatric intensive care units.

Wylie MC, Graham DA, Potter-Bynoe G, Kleinman ME, Randolph AG, Costello JM, Sandora TJ.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1049-56. doi: 10.1086/656246.

PMID:
20731595
17.

Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population.

Wilson MZ, Rafferty C, Deeter D, Comito MA, Hollenbeak CS.

Am J Infect Control. 2014 Nov;42(11):1157-60. doi: 10.1016/j.ajic.2014.07.025. Epub 2014 Oct 30.

PMID:
25444262
18.

Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.

Oh JY, Cunningham MC, Beldavs ZG, Tujo J, Moore SW, Thomas AR, Cieslak PR.

Infect Control Hosp Epidemiol. 2012 May;33(5):439-45. doi: 10.1086/665317. Epub 2012 Mar 21.

PMID:
22476268
19.

The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.

Digiovine B, Chenoweth C, Watts C, Higgins M.

Am J Respir Crit Care Med. 1999 Sep;160(3):976-81.

PMID:
10471627
20.

Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients.

Olaechea PM, Palomar M, Álvarez-Lerma F, Otal JJ, Insausti J, López-Pueyo MJ; ENVIN-HELICS Group.

Rev Esp Quimioter. 2013 Mar;26(1):21-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk